Contrast enhanced ultrasound market worth USD 2.1 billion by 2028

In the near future, the Contrast-Enhanced Ultrasound (CEUS) industry is poised for significant growth and transformative advancements. As medical imaging technology continues to evolve, CEUS will stand out as a safer, more accessible, and cost-effective alternative to traditional imaging modalities like CT scans and MRI. With its non-invasive nature and real-time imaging capabilities, CEUS will become increasingly adopted for various applications, including liver and kidney imaging, vascular assessment, and tumor detection and characterization. The industry will witness rapid developments in contrast agents, improving image quality and diagnostic accuracy. Moreover, advancements in AI-driven image analysis will enhance the interpretation and diagnosis of CEUS studies, empowering healthcare professionals to make quicker and more informed clinical decisions. As research and clinical evidence supporting the benefits of CEUS continue to accumulate, regulatory bodies are likely to expand its approved indications, leading to broader acceptance and integration into routine clinical practice. This growth in the CEUS industry will ultimately translate into improved patient outcomes, better disease management, and a more patient-centric approach to medical imaging in the near future.

Contrast enhanced ultrasound market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 6.1% from 2023 to 2028 according to a new report by MarketsandMarkets™.

The major factors driving the growth of this market include the rising prevalence of chronic diseases and technological developments. Furthermore, contrast-enhanced ultrasound procedures help clinicians with the early detection of chronic diseases and ultimately improve patient outcomes. Contrast agents offer exceptional imaging image clarity and also enable the visualization of blood flow.

Contrast agents’ segment to register a significant growth rate over the forecast period of 2023-2028.

Based on the product, the global contrast-enhanced ultrasound market is segmented into equipment, contrast agents, and software and services. The contrast agents segment is anticipated to register the highest growth rate over the forecast period. The equipment segment accounted for the highest share of the contrast-enhanced ultrasound market in 2022.

The diagnostic application segment accounted for the largest share of the contrast-enhanced ultrasound market by application in 2022.

Based on application, the global contrast-enhanced ultrasound market is segmented into diagnostic applications and therapeutic applications. The diagnostic applications segment accounted for the largest share of the market in 2022, and the therapeutic applications segment is expected to grow at the highest CAGR during the forecast period. Factors such as the introduction of novel software and the rising adoption of high-end instruments in end-user facilities drive the growth of the market.

The hospitals and surgical centers segment accounted for the largest share of the contrast-enhanced ultrasound market, by end-user, in 2022

Based on end users, the global contrast-enhanced ultrasound market is segmented into hospitals and surgical centers, diagnostic imaging clinics, ambulatory surgical centers, and other end users. The hospitals and surgical centers segment accounted for the largest share of the market in 2022. The increasing geriatric population and rise in the number of hospitals are driving the growth of this segment.

The Asia Pacific market to register the highest growth in the market during the forecast period

The Asia Pacific contrast-enhanced ultrasound market is anticipated to register the highest growth from 2023 to 2028. Major players in the market are focusing on expanding their manufacturing capabilities in APAC. This region is consistently witnessing a rise in the adoption of high-end equipment, offering significant growth opportunities for the key players.

Key market players:
As of 2022, prominent players in the contrast-enhanced ultrasound market are GE Healthcare (US), Lantheus Holdings, Inc. (US), Bracco Imaging SpA (Italy), and Koninklijke Philips N.V. (Netherlands), among others. MarketsandMarkets™